Safety and Efficacy of Pyronaridine Artesunate Vs Chloroquine in Children and Adult Patients With Acute Vivax Malaria

Summary

The primary objective of this clinical study is to compare the efficacy and safety of the fixed combination of pyronaridine artesunate (180:60 mg) with that of standard chloroquine therapy in children and adults with acute, uncomplicated Plasmodium vivax (P. vivax) malaria

Timeline

Start

2007-09-06

Primary completion

2010-10-16

Completion

2010-11-15

Outcome

Outcome not reported

Stopped (Enrollment): “Due to slow recruitment the study was terminated prematurely by the Sponsor after 30 subjects had been included”

Drugs

Indications